One Health is a premier open-access journal published by Elsevier, dedicated to advancing the interconnected disciplines of Infectious Diseases and Public Health. Established in 2015, the journal aims to promote holistic approaches to health that consider the interactions between humans, animals, and the environment. With an impressive impact factor and recognition in the top quartiles of both Infectious Diseases and Public Health categories, One Health ranks highly within the Scopus database, showcasing its significant contribution to the field. Situated in the Netherlands, the journal encourages scholarly communication and collaboration, providing a vital platform for researchers, professionals, and students to disseminate their findings and strengthen global health initiatives. By utilizing the open access model, One Health ensures that critical research is freely available, fostering a broader understanding of health-related issues that span multiple sectors.

The Italian Journal of Pediatrics, an esteemed publication within the field of Pediatrics, has been advancing pediatric research and discourse since its inception in 1992. Published by BMC and operating as an Open Access journal since 2008, it ensures that critical findings are readily available to a global audience to enhance child health outcomes. With an impressive Q1 ranking in the category of Pediatrics, Perinatology and Child Health, it stands among the top journals in its field, boasting a Scopus ranking of #43 out of 330, placing it in the 87th percentile. Researchers, healthcare professionals, and students will find valuable insights and innovative research that target the latest advancements in pediatric medicine, making it an essential resource for those dedicated to improving health for children everywhere. The journal's dedication to excellence is reflected in both its impactful publications and its commitment to fostering collaboration and knowledge exchange among practitioners around the world.

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

JOURNAL OF TROPICAL PEDIATRICS, published by Oxford University Press, stands as a critical platform for the dissemination of research and clinical advancements in the field of tropical pediatrics. With a rich history dating back to 1955, this journal serves as a significant contributor to our understanding of health issues affecting children in tropical and subtropical regions, focusing on infectious diseases, pediatric care, and child health. It currently holds an impressive Q2 ranking in three categories: Infectious Diseases, Medicine (miscellaneous), and Pediatrics, Perinatology and Child Health, placing it among the top journals in its field. Featuring both formative research and applied studies, the journal aims to address the unique challenges posed by pediatric care in tropical environments. Its inclusion in an esteemed database ensures a broad dissemination of critical knowledge to researchers, healthcare professionals, and students alike, promoting a collaborative approach to improving child health outcomes globally.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

Vaccine: X, published by Elsevier, is a premier open access journal dedicated to advancing research in the interdisciplinary fields of immunology and microbiology, infectious diseases, molecular medicine, and public health. With an ISSN of 2590-1362 and operating since 2019, the journal has rapidly established an influential role, achieving Q2 rankings in major categories such as Immunology and Microbiology, Infectious Diseases, and Public Health for 2023. Its commitment to disseminating cutting-edge research is evident from its broad scope, focusing on innovative vaccines and therapies that are critical for global health. Researchers and professionals will find value in the accessible nature of the journal, which has been recognized for its contributions to veterinary medicine as well, with a Q1 ranking in the miscellaneous veterinary category. The journal proudly showcases high-quality, peer-reviewed articles and welcomes submissions that push the boundaries of current knowledge, making it an essential resource for anyone involved in vaccine research and development.

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.

The Lancet, established in 1823, is one of the most prestigious peer-reviewed journals in the field of medicine, published by Elsevier Science Inc. Renowned for its rigorous standards and commitment to high-quality research, this journal occupies a leading position in the academic world, holding an impressive Q1 category ranking in Medicine (miscellaneous) as of 2023, and ranking #1 out of 636 in the general medicine category with a remarkable 99th percentile according to Scopus. With an emphasis on global health, clinical practice, and medical policy, The Lancet aims to disseminate innovative research that pushes the boundaries of medical knowledge and informs practice worldwide. Although it does not currently offer Open Access options, its high impact factor and historical significance make it an essential resource for researchers, healthcare professionals, and students committed to advancing health and medicine. Engaging with this journal ensures staying at the forefront of critical developments in the medical field.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.